NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001862

Registered date:01/06/2009

A multicenter study on early prediction of antipsychotic response in patients with schizophrenia

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedschizophrenia
Date of first enrollment2009/07/01
Target sample size500
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)olanzapine/risperidone risperidone/olanzapine

Outcome(s)

Primary OutcomeThe rate of remission at 4 weeks after the beginning of antipsychotics
Secondary Outcomethe Positive and Negative Syndrome Scale (PANSS) ,Clinical Global Impression Change rating scale,Global Assessment of Functioning,the Drug-induced Extrapyramidal Symptom Scale ,blood sugar, total cholesterol, triglyceride

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum65years-old
GenderMale and Female
Include criteria
Exclude criteria1) severe liver, renal, respiratory, or cardiac dysfunction 2) diabetes melitus or its history 3) women during pregnancy or nurse, women who want to get pregnant

Related Information

Contact

public contact
Name Kotaro Hatta
Address 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan Japan
Telephone 03-5802-1071
E-mail khatta@juntendo.ac.jp
Affiliation Juntendo University School of Medicine Department of Psychiatry
scientific contact
Name Kotaro Hatta
Address 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan Japan
Telephone 03-5802-1071
E-mail khatta@juntendo.ac.jp
Affiliation Juntendo University School of Medicine Department of Psychiatry